GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

Several companies such as Shriram Finance, Symphony, etc. will be in focus today on account of corporate actions.

The split is no surprise: it has been public knowledge since the end of 2018 that GSK is going to spin off its consumer health business into a joint venture with Pfizer, but this is the first time ...

GlaxoSmithKline’s chairman, Philip Hampton, may be considering splitting the company amid pressure from top investors to separate the company into consumer, pharma and vaccines divisions.

Dividend, stock split: Navin Fluorine International, Nuvama Wealth Management, Share India Securities, Shriram Finance Ltd, ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

At its recent annual meeting in Chicago, the Easterseals National Board of Directors named disability advocate and Founder & CEO of The Split Second Foundation (SSF) Mark Raymond, Jr., to its board ...

French media giant Canal+ has set a date for its planned float on the London Stock Exchange today in what could be the ...

After decades as a political outsider, Sanders has used his committee chairmanships and proximity to the White House to ...

The media giant would separate from the Paris-based conglomerate and is expected to float in London on 16 December, according ...

Healthcare is possibly the most overlooked of all the mega-trends. But this may leave investors with more opportunities once ...